1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with epidermal growth factor in 20 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (epidermal growth factor) | Trials (epidermal growth factor) | Recent Studies (post-2010) (epidermal growth factor) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 24,155 | 217 | 4,699 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (10.00) | 18.7374 |
| 1990's | 10 (50.00) | 18.2507 |
| 2000's | 4 (20.00) | 29.6817 |
| 2010's | 4 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bry, K; Hallman, M | 1 |
| Alila, HW; Battista, PJ; Hansel, W; Rexroad, CE | 1 |
| Kosano, H; Takatani, O | 1 |
| Rhee, SG; Shukla, SD; Thurston, AW | 1 |
| Kravchenko, VV; Pan, Z; Ye, RD | 1 |
| Chen, LL; Kreutzer, DL; Mann, EA; Spiro, JD | 1 |
| Goff, AK; Slama, H; Vaillancourt, D | 2 |
| Bull, DA; Hendrix, MJ; Hunter, GC; Larson, DF; Putnam, CW; Seftor, EA | 1 |
| O'Neill, C | 2 |
| Arnautova, IP; Gamaleĭ, IA; Kirpichnikova, KM; Kliubin, IV | 1 |
| Guo, XZ; Jin, Y; Li, L; Tan, LL; Xie, CY | 1 |
| Hynes, AC; Kane, MT; Sreenan, JM | 1 |
| Fell, JM | 1 |
| Ibe, BO; Raj, JU; Zhou, W | 1 |
| Cerkiene, Z; Eidukaite, A; Usoniene, A | 1 |
| Aksoy, OA; Aslan, S; Beceriklisoy, HB; Kanca, H; Klein, D; Kucukaslan, I; Macun, HC; Reinbacher, E; Sabitzer, S; Schäfer-Somi, S | 1 |
| Cai, Q; Hong, S; Jiang, W; Xu, C; Yu, Y; Zhang, M; Zhang, X | 1 |
| Goldstein, GP; Sylvester, KG | 1 |
3 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and epidermal growth factor
| Article | Year |
|---|---|
Neonatal inflammatory intestinal diseases: necrotising enterocolitis and allergic colitis.
Topics: Colitis; Enterocolitis, Necrotizing; Epidermal Growth Factor; Gastrointestinal Tract; Humans; Infant, Newborn; Platelet Activating Factor | 2005 |
Immune factors in human embryo culture and their significance.
Topics: Animals; Colony-Stimulating Factors; Embryo Culture Techniques; Embryo Implantation; Embryonic Development; Epidermal Growth Factor; Female; Fertilization in Vitro; Fetal Viability; Humans; Mice; Platelet Activating Factor; Platelet-Derived Growth Factor; Pregnancy; Somatomedins; Transforming Growth Factors | 2010 |
Biomarker Discovery and Utility in Necrotizing Enterocolitis.
Topics: Alpha-Globulins; Biomarkers; Blood Cell Count; Breath Tests; C-Reactive Protein; Claudins; Complement C5a; Cytokines; Early Diagnosis; Enterocolitis, Necrotizing; Epidermal Growth Factor; Fatty Acid-Binding Proteins; Gastrointestinal Microbiome; Genomics; Humans; Hydrogen; Infant, Newborn; Infant, Premature; Leukocyte L1 Antigen Complex; Metabolomics; Platelet Activating Factor; Procalcitonin; Prognosis; Proteomics; Risk Assessment; S100A12 Protein; Sensitivity and Specificity; Serum Albumin, Human; Serum Amyloid A Protein; Spectroscopy, Near-Infrared; Trefoil Factor-3; Ultrasonography; Volatile Organic Compounds | 2019 |
17 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and epidermal growth factor
| Article | Year |
|---|---|
A product of activated human granulocytes stimulates prostaglandin E2 synthesis in human amnion cells.
Topics: Amnion; Cells, Cultured; Chorioamnionitis; Cytochalasin B; Dinoprostone; Epidermal Growth Factor; Female; Free Radical Scavengers; Granulocytes; Hot Temperature; Humans; Indomethacin; Labor, Obstetric; N-Formylmethionine Leucyl-Phenylalanine; Obstetric Labor, Premature; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Pregnancy; Protein Synthesis Inhibitors; Stimulation, Chemical | 1991 |
The effects of platelet-activating factor and platelet-derived compounds on bovine luteal cell progesterone production.
Topics: Animals; Blood Platelets; Cattle; Chromatography, High Pressure Liquid; Corpus Luteum; Epidermal Growth Factor; Female; Indomethacin; Luteinizing Hormone; Mianserin; Platelet Activating Factor; Platelet Aggregation; Platelet-Derived Growth Factor; Progesterone; Propranolol; Serotonin | 1989 |
Reduction of epidermal growth factor binding in human breast cancer cell lines by an alkyl-lysophospholipid.
Topics: Antineoplastic Agents; Breast Neoplasms; Epidermal Growth Factor; ErbB Receptors; Female; Humans; Phosphatidylcholines; Phospholipid Ethers; Platelet Activating Factor; Protein Kinase C; Tumor Cells, Cultured | 1988 |
Role of guanine nucleotide-binding protein and tyrosine kinase in platelet-activating factor activation of phospholipase C in A431 cells: proposal for dual mechanisms.
Topics: Carcinoma, Squamous Cell; Enzyme Activation; Epidermal Growth Factor; GTP Phosphohydrolases; GTP-Binding Proteins; Humans; Phosphorylation; Platelet Activating Factor; Platelet Membrane Glycoproteins; Protein-Tyrosine Kinases; Proto-Oncogene Proteins pp60(c-src); Receptors, Cell Surface; Receptors, G-Protein-Coupled; Tumor Cells, Cultured; Type C Phospholipases | 1993 |
Platelet-activating factor stimulates transcription of the heparin-binding epidermal growth factor-like growth factor in monocytes. Correlation with an increased kappa B binding activity.
Topics: Bacterial Toxins; Base Sequence; DNA Primers; Epidermal Growth Factor; Gene Expression Regulation; Heparin; Heparin-binding EGF-like Growth Factor; Humans; Intercellular Signaling Peptides and Proteins; Molecular Sequence Data; Monocytes; NF-kappa B; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Transcription, Genetic | 1995 |
Phospholipid metabolite expression by head and neck squamous cell carcinoma.
Topics: Aged; Analysis of Variance; Animals; Carcinoma, Squamous Cell; Dinoprostone; Epidermal Growth Factor; Evaluation Studies as Topic; Fibroblasts; Head and Neck Neoplasms; Humans; Immune Tolerance; Interleukin-1; Leukotriene B4; Lipopolysaccharides; Middle Aged; Neoplasm Staging; Phenotype; Platelet Activating Factor; Radioimmunoassay; Regression Analysis; Tumor Cells, Cultured | 1994 |
Control of in vitro prostaglandin F2 alpha and E2 synthesis by caruncular and allantochorionic tissues from cows that calved normally and those with retained fetal membranes.
Topics: Allantois; Animals; Calcium; Cattle; Cattle Diseases; Chorion; Culture Techniques; Dinoprost; Dinoprostone; Epidermal Growth Factor; Estradiol; Extraembryonic Membranes; Female; Labor Stage, Third; Obstetric Labor Complications; Oxytocin; Placenta; Platelet Activating Factor; Pregnancy; Protein Kinase C | 1994 |
Putative vascular endothelial cell chemotactic factors: comparison in a standardized migration assay.
Topics: Adenosine; Animals; Cattle; Cells, Cultured; Chemotactic Factors; Chemotaxis; Endothelium, Vascular; Epidermal Growth Factor; Fibrinogen; Granulocyte-Macrophage Colony-Stimulating Factor; Growth Substances; Magnesium Sulfate; Platelet Activating Factor; Platelet-Derived Growth Factor; Pulmonary Artery; Transforming Growth Factor alpha | 1993 |
Metabolism of arachidonic acid by caruncular and allantochorionic tissues in cows with retained fetal membranes (RFM).
Topics: 6-Ketoprostaglandin F1 alpha; Allantois; Animals; Arachidonic Acid; Calcium; Cattle; Chorion; Chromatography, High Pressure Liquid; Dinoprost; Dinoprostone; Epidermal Growth Factor; Female; Hydroxyeicosatetraenoic Acids; Leukotriene B4; Oxytocin; Placenta; Placenta Diseases; Platelet Activating Factor; Pregnancy; Thromboxane B2 | 1993 |
Evidence for the requirement of autocrine growth factors for development of mouse preimplantation embryos in vitro.
Topics: Animals; Blastocyst; Culture Media; Culture Techniques; Embryonic and Fetal Development; Embryonic Development; Epidermal Growth Factor; Female; Fertilization in Vitro; Growth Substances; Humans; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Mice; Platelet Activating Factor; Pregnancy; Serum Albumin, Bovine; Zygote | 1997 |
Role of autocrine mediators in the regulation of embryo viability: lessons from animal models.
Topics: Animals; Autocrine Communication; Chromosome Aberrations; Embryonic and Fetal Development; Epidermal Growth Factor; Female; Fertilization in Vitro; Growth Substances; Humans; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Male; Mice; Platelet Activating Factor; Pregnancy; Rats; Zygote | 1998 |
[Post-receptor formation of active forms of oxygen in nonphagocytic cells].
Topics: Animals; Cell Line; Epidermal Growth Factor; ErbB Receptors; Interferon-gamma; Lipopolysaccharides; Mice; N-Formylmethionine Leucyl-Phenylalanine; Phagocytes; Platelet Activating Factor; Reactive Oxygen Species; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1999 |
[The effect of autocrine factors on development of early embryos of mouse].
Topics: Animals; Blastocyst; Culture Techniques; Embryonic and Fetal Development; Epidermal Growth Factor; Female; Insulin-Like Growth Factor I; Mice; Platelet Activating Factor; Zygote | 2001 |
The phosphatidylinositol signalling system in elongating bovine blastocysts; formation of phosphoinositides, inositol phosphates and stimulation by growth factors.
Topics: Animals; Blastocyst; Cattle; Epidermal Growth Factor; Growth Substances; Inositol; Inositol Phosphates; Lysophospholipids; Phosphatidylinositols; Platelet Activating Factor; Signal Transduction; Sodium; Tritium; Type C Phospholipases | 2002 |
Platelet-activating factor induces ovine fetal pulmonary venous smooth muscle cell proliferation: role of epidermal growth factor receptor transactivation.
Topics: Animals; Bacterial Proteins; Cell Proliferation; Cells, Cultured; Dipeptides; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Heparin-binding EGF-like Growth Factor; Intercellular Signaling Peptides and Proteins; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Muscle, Smooth, Vascular; Mutation; Myocytes, Smooth Muscle; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Platelet Activating Factor; Pulmonary Veins; Quinazolines; Sheep; Signal Transduction; Time Factors; Transfection; Tyrphostins | 2007 |
Vascular endothelial (VEGF) and epithelial growth factor (EGF) as well as platelet-activating factor (PAF) and receptors are expressed in the early pregnant canine uterus.
Topics: Animals; Dogs; Embryo Implantation; Epidermal Growth Factor; ErbB Receptors; Female; Gene Expression Regulation; Placenta; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pregnancy; Receptors, G-Protein-Coupled; Receptors, Vascular Endothelial Growth Factor; Reverse Transcriptase Polymerase Chain Reaction; RNA; Uterus; Vascular Endothelial Growth Factor A | 2013 |
Epidermal growth factor induces platelet-activating factor production through receptors transactivation and cytosolic phospholipase A2 in ovarian cancer cells.
Topics: Cell Line, Tumor; Epidermal Growth Factor; ErbB Receptors; Humans; Phospholipases A2, Cytosolic; Phosphorylation; Platelet Activating Factor; Platelet Membrane Glycoproteins; Protein Processing, Post-Translational; Receptors, G-Protein-Coupled; Signal Transduction; Transcriptional Activation | 2014 |